Bioregenx (BRGX) Total Liabilities (2021 - 2026)

Bioregenx's Total Liabilities history runs 6 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 20.51% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 20.51% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 27.28% from the prior year.
• Total Liabilities declined to $4.9 million in Q1 2026 per BRGX's latest filing, from $4.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $4.9 million in Q4 2025 and bottomed at $234923.0 in Q1 2023.
• The 5-year median for Total Liabilities is $3.7 million (2024), against an average of $3.0 million.
• Across the five-year window, Total Liabilities soared 1480.07% in 2024 and increased 14.34% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $260691.0 in 2022, then jumped by 1026.69% to $2.9 million in 2023, then jumped by 32.36% to $3.9 million in 2024, then gained by 27.28% to $4.9 million in 2025, then fell by 1.57% to $4.9 million in 2026.
• Per Business Quant, the three latest BRGX Total Liabilities figures stand at $4.9 million (Q1 2026), $4.9 million (Q4 2025), and $4.8 million (Q3 2025).